Should the routinary determination of plasmatic fibrinogen as vascular risk indicative parameter be included in the metabolic syndrome patient?
M.V Zunzunegui-Pastor, F.M Gómez-Trujillo, J.S Luque-Martin, J.J Sánchez-Luque, C Ortiz-Garcı́a, M.J Ferreras-Duarte, I García-CaravacaVolume:
14
Year:
2001
Language:
english
DOI:
10.1016/s0895-7061(01)01633-8
File:
PDF, 46 KB
english, 2001